CRISPR and Genome Editing – News and Features

BIOTECON gains authorization to develop, produce, and sell kits in the food and GMO analysis field that are designed for use on the Roche LightCycler Instrument.

The webinar imparts knowledge about setting up embryonic, mesenchymal, hematopoietic or neural stem cell experiments using Nucleofector® Technology.

Penn researchers used gene therapy to safely restore vision in three young adults with a rare form of congenital blindness.

A TATAA Biocenter researcher has performed a 3-way expression profiling study of the metabolism of Saccharomyces cerevisiae also called baker’s yeast.

The "Sticky siRNA" technology is already being tested in vivo by academic laboratories and biotech companies.

The companies collaborate to deliver cloned gene content ready for multiple proteomics applications.

BCM and 454 achieve a key milestone on the path to personalized genome sequencing by establishing quality standard for the routine sequencing of humans.

A team of North American scientists has unveiled a new technology that could revolutionize the industrialization and commercialization of stem cell therapies.

A team of North American scientists has unveiled a new technology that could revolutionize the industrialization and commercialization of stem cell therapies.

Researchers shows that therapeutic cloning has been used to treat disease in the same subjects from whom the initial cells were derived.